Fate Therapeutics Inc. (FATE)
NASDAQ: FATE
· Real-Time Price · USD
1.09
0.02 (1.87%)
At close: Aug 15, 2025, 3:59 PM
1.14
4.11%
After-hours: Aug 15, 2025, 07:57 PM EDT
Fate Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 41.25M | 44.92M | 36.06M | 37.91M | 36.92M | 121.32M | 41.87M | 33.33M | 46.8M | 42.02M | 61.33M | 82.09M | 55.27M | 64.74M | 133.58M | 129.18M | 76.65M | 106.41M |
Short-Term Investments | 181.58M | 195.5M | 243.01M | 259.01M | 267.96M | 262.22M | 273.31M | 316.4M | 331.13M | 366.88M | 374.89M | 423.04M | 513.58M | 509.03M | 482.33M | 549.52M | 618.94M | 683.72M |
Long-Term Investments | 26.1M | 32.29M | 27.66M | 33.61M | 47.16M | 22.77M | 16.16M | n/a | 7.29M | 3.91M | 4.94M | 13.94M | 11.93M | 67.94M | 100.66M | 124.88M | 149.5M | 98.28M |
Other Long-Term Assets | 10.23M | 10.23M | 10.24M | 10.24M | 15.19M | 9K | 9K | 15.19M | 15.21M | 15.26M | 132.48M | 23.59M | 24.37M | 24.04M | 116.66M | 26.39M | 27.5M | 28.12M |
Receivables | 1.4M | 2.41M | 3.54M | 4.13M | 1.05M | 1.76M | 1.83M | 1.54M | 2.83M | 13.5M | 38.48M | 10.22M | 13.13M | 13.85M | 8.68M | 7.31M | 10.3M | 6.95M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 6.17M | 5.39M | 9.3M | 1.9M | 1.7M | n/a | 900K | 12.9M | 11.41M | 15.49M | 27.37M | n/a | n/a | n/a | 8.83M | n/a | n/a | n/a |
Total Current Assets | 230.4M | 248.22M | 291.91M | 310.29M | 319.39M | 394.38M | 331.54M | 364.17M | 392.18M | 437.89M | 502.07M | 535.33M | 599.16M | 599.08M | 633.41M | 693.71M | 713.27M | 804.32M |
Property-Plant & Equipment | 104.91M | 107.94M | 110.89M | 140.83M | 147.08M | 152.74M | 158.51M | 164.43M | 170.07M | 173.28M | 66.07M | 176.5M | 171.61M | 167.33M | 70.72M | 139.59M | 125.4M | 115.25M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 141.24M | 150.45M | 148.78M | 184.68M | 209.43M | 175.52M | 174.68M | 179.61M | 192.57M | 192.45M | 203.49M | 214.02M | 207.9M | 259.31M | 288.04M | 290.86M | 302.4M | 241.65M |
Total Assets | 371.63M | 398.67M | 440.69M | 494.97M | 528.82M | 569.89M | 506.22M | 543.79M | 584.76M | 630.34M | 705.56M | 749.35M | 807.06M | 858.39M | 921.46M | 984.57M | 1.02B | 1.05B |
Account Payables | 4.04M | 4.19M | 9.37M | 6.35M | 5.5M | 6.76M | 4.72M | 5.71M | 7.51M | 9.86M | 8.27M | 9.59M | 8.42M | 11.44M | 8.61M | 6.44M | 5.77M | 9M |
Deferred Revenue | n/a | 212K | 393K | 600K | n/a | 159K | 685K | 1.11M | 1.93M | 1.74M | 42.23M | 35.24M | 33.66M | 22.57M | 21.48M | 23.55M | 23.03M | 21.03M |
Short-Term Debt | 5.66M | n/a | n/a | n/a | n/a | 6.4M | 6.18M | 5.98M | 5.79M | 5.54M | n/a | 5.75M | 5.72M | 5.58M | n/a | 4.7M | 5.07M | 4.41M |
Other Current Liabilities | 11.86M | n/a | 11.64M | n/a | 15.39M | 20.23M | -6.18M | -5.98M | 15.29M | 19.93M | 40.03M | 30.19M | 21.45M | 21.16M | 27.25M | 40.31M | 56.75M | 47.35M |
Total Current Liabilities | 28.67M | 28.16M | 38.52M | 37.42M | 34.79M | 45.37M | 39.09M | 41.33M | 44.69M | 48.65M | 114.05M | 103.94M | 91.52M | 77.91M | 81.28M | 91.88M | 105.6M | 94.58M |
Long-Term Debt | 75.67M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 5.92M | 5.32M | 5.6M | 3.14M | 3.12M | 2.74M | 1.35M | 701K | 1.75M | 2.14M | 3.86M | 9.84M | 10.73M | 16.61M | 24.97M | 25.43M | 13.66M | 11.76M |
Total Long-Term Liabilities | 81.59M | 82.1M | 83.45M | 95.22M | 97.04M | 98.41M | 98.71M | 99.68M | 102.31M | 104.21M | 107.57M | 127.41M | 135.06M | 147.08M | 161.33M | 162.35M | 158M | 161.29M |
Total Liabilities | 110.27M | 110.26M | 121.97M | 132.64M | 131.84M | 143.78M | 137.8M | 141.01M | 147M | 152.86M | 221.62M | 231.35M | 226.58M | 224.99M | 242.62M | 254.24M | 263.6M | 255.87M |
Total Debt | 81.33M | 83.33M | 85.27M | 98.98M | 100.56M | 102.07M | 103.54M | 104.95M | 106.35M | 107.61M | 109.34M | 110.92M | 112.3M | 113.52M | 114.82M | 109.06M | 110.47M | 110.92M |
Common Stock | 115K | 115K | 114K | 114K | 114K | 114K | 99K | 99K | 99K | 98K | 97K | 97K | 97K | 97K | 96K | 95K | 94K | 94K |
Retained Earnings | -1.47B | -1.44B | -1.4B | -1.35B | -1.3B | -1.26B | -1.21B | -1.17B | -1.12B | -1.07B | -1.05B | -994.44M | -910.88M | -834.77M | -769.08M | -700.46M | -657.15M | -602.02M |
Comprehensive Income | 62K | 191K | 268K | 835K | -422K | -194K | 15K | -499K | -587K | -646K | -1.85M | -3.25M | -3.38M | -2.85M | -762K | -73K | -86K | -260K |
Shareholders Equity | 261.36M | 288.41M | 318.73M | 362.33M | 396.98M | 426.12M | 368.42M | 402.78M | 437.75M | 477.47M | 483.94M | 518M | 580.48M | 633.39M | 678.84M | 730.33M | 752.07M | 790.1M |
Total Investments | 207.68M | 227.79M | 270.67M | 292.62M | 315.12M | 284.99M | 289.46M | 316.4M | 338.42M | 370.79M | 379.84M | 436.98M | 525.5M | 576.97M | 582.99M | 674.4M | 768.44M | 782.01M |